Drug
Pioglitazone Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Vasculitis | 44 | 64.2 | 66.5 | signal |
| 2 | Arteriosclerosis | 35 | 63.1 | 64.9 | signal |
| 3 | Full Blood Count Abnormal | 34 | 54.8 | 56.3 | signal |
| 4 | Obstructive Airways Disorder | 32 | 48.7 | 50.0 | signal |
| 5 | Nodule | 36 | 46.8 | 48.2 | signal |
| 6 | Sleep Disorder Due To A General Medical Condition | 43 | 45.2 | 46.7 | signal |
| 7 | Pulmonary Fibrosis | 32 | 28.4 | 29.1 | signal |
| 8 | Clostridium Difficile Colitis | 14 | 22.4 | 22.6 | signal |
| 9 | Haemoptysis | 35 | 21.2 | 21.8 | signal |
| 10 | Hypoglycaemia | 60 | 21.0 | 22.0 | signal |
| 11 | Hypothyroidism | 35 | 18.6 | 19.1 | signal |
| 12 | Cardiomegaly | 13 | 17.8 | 17.9 | signal |
| 13 | Diabetes Mellitus Inadequate Control | 18 | 17.2 | 17.5 | signal |
| 14 | Hypoxia | 35 | 16.9 | 17.4 | signal |
| 15 | Glycosylated Haemoglobin Increased | 22 | 14.8 | 15.1 | signal |
| 16 | Productive Cough | 38 | 13.6 | 14.0 | signal |
| 17 | Diabetic Ketoacidosis | 19 | 13.4 | 13.6 | signal |
| 18 | Lactic Acidosis | 25 | 13.2 | 13.5 | signal |
| 19 | Loss Of Personal Independence In Daily Activities | 37 | 13.2 | 13.6 | signal |
| 20 | Wheezing | 46 | 13.2 | 13.6 | signal |
| 21 | Poor Venous Access | 8 | 13.1 | 13.2 | signal |
| 22 | Haemorrhoids | 14 | 12.1 | 12.3 | signal |
| 23 | Hyperglycaemia | 26 | 12.1 | 12.4 | signal |
| 24 | Body Temperature Decreased | 7 | 11.9 | 12.0 | signal |
| 25 | Lung Disorder | 34 | 11.8 | 12.1 | signal |
| 26 | Therapeutic Product Effect Incomplete | 47 | 11.3 | 11.7 | signal |
| 27 | Blood Glucose Abnormal | 12 | 11.0 | 11.1 | signal |
| 28 | Thrombosis | 51 | 10.7 | 11.1 | signal |
| 29 | Inflammatory Bowel Disease | 6 | 10.3 | 10.4 | signal |
| 30 | Hypercalcaemia | 7 | 9.6 | 9.7 | signal |
| 31 | Hyperkalaemia | 19 | 9.2 | 9.4 | signal |
| 32 | Pancreatitis Acute | 11 | 8.4 | 8.4 | signal |
| 33 | Renal Failure Acute | 20 | 7.9 | 8.0 | signal |
| 34 | Cardiac Failure | 37 | 7.8 | 8.0 | signal |
| 35 | Blood Pressure Systolic Increased | 9 | 7.8 | 7.8 | signal |
| 36 | Cerebral Infarction | 11 | 7.6 | 7.7 | signal |
| 37 | Acute Myocardial Infarction | 13 | 7.4 | 7.5 | signal |
| 38 | Hepatic Function Abnormal | 16 | 7.3 | 7.4 | signal |
| 39 | Altered State Of Consciousness | 9 | 7.1 | 7.1 | signal |
| 40 | Transient Ischaemic Attack | 14 | 7.0 | 7.1 | signal |
| 41 | Skin Exfoliation | 29 | 5.9 | 6.0 | signal |
| 42 | Blood Glucose Decreased | 15 | 5.3 | 5.3 | signal |
| 43 | Bladder Cancer | 17 | 4.8 | 4.9 | signal |
| 44 | Blood Glucose Increased | 52 | 4.7 | 4.8 | signal |
| 45 | Blood Glucose Fluctuation | 3 | 4.6 | 4.6 | signal |
| 46 | Osteonecrosis Of Jaw | 6 | 4.1 | 4.1 | signal |
| 47 | Cytomegalovirus Infection | 4 | 4.1 | 4.1 | signal |
| 48 | Sopor | 3 | 3.8 | 3.8 | no signal |
| 49 | Pancreatic Carcinoma | 6 | 3.5 | 3.5 | signal |
| 50 | Application Site Erythema | 4 | 2.6 | 2.6 | no signal |
| 51 | Wrong Technique In Drug Usage Process | 5 | 2.3 | 2.3 | no signal |
| 52 | Hepatic Cancer | 3 | 2.1 | 2.1 | no signal |
| 53 | Gynaecomastia | 3 | 1.6 | 1.6 | no signal |